![](/img/cover-not-exists.png)
Immunopharmacological effect of β‐ d ‐mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR‐155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients
Mortazavi‐Jahromi, Seyed Shahabeddin, Aslani, Mona, Omidian, Saiedeh, Ahmadzadeh, Arman, Rezaieyazdi, Zahra, Mirshafiey, AbbasLanguage:
english
Journal:
Drug Development Research
DOI:
10.1002/ddr.21619
Date:
November, 2019
File:
PDF, 1.65 MB
english, 2019